Clinical Study for the Treatment of Cardiomyopathy
Study Reference:
Nucleus Network - Minneapolis
Compensation
Up to
$8750
Recruiting
Study Details
This is a clinical study to assess the similarity of 1x 15mg dose versus 3x 5mg dose of mavacamten for the treatment of cardiomyopathy. This study is to assess how a capsule is processed in the body when given different formulations of an FDA approved medication.
Study Period
This study has two separate admits each of 4 nights and 5 days & 11 outpatient visits over 4 months.
Compensation
up to $8,750
Eligibility Criteria
- Age:18-60
- BMI:18-32kg/m2
- Medication: Any prescription medications within 28 days or OTC medications within 14 days prior to dosing.
- Contraception: Willing to adhere to the contraception requirements for this study
- Smoking Status: Must not have used any tobacco products within 2 months prior to dose
Research Location:
Nucleus Network - Minneapolis
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
60
BMI: 18-
32
Smokers Allowed: Yes
Share with a Friend
Company Information
Nucleus Network
Nucleus Network is a leading clinical research organization for the conduct of Early Phase Clinical Trials— its people, facilities and problem-solving culture provide excellent service to global pharmaceutical and biotechnology companies. The organization is an instrumental part of the process for the development of global investigational products.
Contact Information
+16516412900
Suite 149, St. Paul
Minneapolis, MN 55114
United States
Share with a Friend
Other Trials for You
Closed
Featured
Start Date: April 13, 2023 (check-in)
The primary purpose of Part A is to determine the safety and tolerability (side effects) of single doses of the study drug at increasing dose levels. You will be given a single, oral dose of the study drug or a placebo (inactive drug).
Compensation Up to
: $2346
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Closed
Start Date: April 13, 2023 (check-in)
Compensation:
Up to
$2346
Labcorp - Daytona Beach
The primary purpose of Part A is to determine the safety and tolerability (side effects) of single doses of the study drug at increasing dose levels. You will be given a single, oral dose of the study drug or a placebo (inactive drug).
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Not yet recruiting
Featured
CenExel ACT is looking for male and female volunteers for psoriasis study.
Compensation Up to
: $
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
CenExel ACT - Anaheim
CenExel ACT is looking for male and female volunteers for psoriasis study.
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Recruiting
Featured
Start Date: April 24, 2023 (check-in)
Altasciences in Overland Park is looking for healthy elderly volunteers for a clinical research study.
Compensation Minimum
: $8250
BMI: 65-
85
Volunteer: Healthy
Gender: Man, Woman
Age: 65-
85
Smokers Allowed: No
Recruiting
Start Date: April 24, 2023 (check-in)
Compensation:
Minimum
$8250
Altasciences - Overland Park
Altasciences in Overland Park is looking for healthy elderly volunteers for a clinical research study.
BMI: 65-
85